Satellos’ lead drug candidate SAT-3247 gets INN “forazapadin”
Satellos Bioscience announced assignment of the International Nonproprietary Name “forazapadin” for its lead drug candidate, SAT-3247.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Satellos Bioscience announced assignment of the International Nonproprietary Name “forazapadin” for its lead drug candidate, SAT-3247.